Merck & Co Inc (NYSE:MRK)

61.47
Delayed Data
As of Jun 22
 +0.29 / +0.47%
Today’s Change
52.83
Today|||52-Week Range
66.41
+9.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$160.6B

Company Description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as vaccines, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Contact Information

Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth New Jersey 07033
P:(908) 740-4000
Investor Relations:
(908) 740-1986

Employees

Shareholders

Mutual fund holders40.98%
Other institutional35.10%
Individual stakeholders0.10%

Top Executives

Kenneth C. FrazierChairman, President & Chief Executive Officer
Robert M. DavisCFO & Executive Vice President-Global Services
Ashley WatsonSenior VP, Chief Ethics & Compliance Officer
Adam H. SchechterExecutive VP & President-Global Human Health
Richard R. DeLucaExecutive Vice President & President-Animal Health